WA
JAZZ icon

WPG Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

WPG Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.5K Buy
384
+44
+13% +$9.64K 0.05% 200
2026
Q1 		$64.3K Sell
340
-14
-4% -$2.45K 0.05% 226
2025
Q4 		$60.2K Sell
354
-11
-3% -$1.69K 0.04% 255
2025
Q3 		$48.1K Buy
365
+30
+9% +$3.6K 0.04% 299
2025
Q2 		$35.5K Buy
335
+275
+458% +$29.9K 0.03% 354
2025
Q1 		$7.45K Buy
60
+37
+161% +$4.83K 0.01% 737
2024
Q4 		$2.83K Buy
+23
New +$2.71K ﹤0.01% 997

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

WPG Advisers's JAZZ Position: Q2 2026 in Review

WPG Advisers increased its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q2 2026, buying an estimated $9.64K and bringing the position to 384 shares worth $92.5K. The position accounts for 0.05% of the portfolio, ranked #200.

WPG Advisers first reported a position in JAZZ in Q4 2024 and has held it in 7 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • WPG Advisers held 384 shares of Jazz Pharmaceuticals worth $92.5K as of Q2 2026.
  • WPG Advisers bought 44 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.64K.
  • Jazz Pharmaceuticals made up 0.05% of WPG Advisers's portfolio in Q2 2026, its #200 holding.
  • WPG Advisers first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.